Drug Index

OMNIPEN (AMPICILLIN)

Generic: AMPICILLIN/AMPICILLIN TRIHYDRATE

Marketing status: Discontinued

Route: ORAL
Class: General Medications
Safety profile: generic
Latest regulatory update: 13 Aug 1996, 12:00 am (UTC)

Structured Monograph

Approval overview OMNIPEN (AMPICILLIN) is listed in Drugs@FDA under application 060624 (ANDA). Marketing status: Discontinued Active ingredient AMPICILLIN/AMPICILLIN TRIHYDRATE Form and strength CAPSULE;ORAL - 250MG Sponsor WYETH AYERST Submission history Latest submission status date: 1996-08-13 00:00:00. Submission type: SUPPL.